A research team led by Albert Einstein College of Medicine scientists has developed a new strategy to engineer immune cells ...
For decades, cancer immunotherapy has focused primarily on CD8+ cytotoxic T lymphocytes as the main executors of tumor cell ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results